The med-tech company PolarCool AB (publ.) announces that three national teams qualified for the FIFA World Cup 2026 in North America will have access to PolarCap® during the tournament. Treatment with PolarCap® will be included in the teams' medical protocols for players who suffer a concussion during the tournament.

PolarCool's CEO Erik Andersson comments:

-The use of PolarCap® at the world's biggest football tournament sends a strong signal about the growing importance of early concussion treatment in elite football. We are very proud that several national teams competing at the highest level of international football have chosen to include PolarCap® as part of their routines to protect their players.

Football is a strategically important market for PolarCool due to the sport's global reach and the increasing focus on head injuries and concussion management. The decision by several World Cup teams to make PolarCap® available during the tournament is of significant strategic value to PolarCool, even though the direct financial impact is limited. It underscores the growing recognition of the importance of early intervention in concussion cases and strengthens PolarCool's position as the leading player in acute concussion treatment.